Table of Content




Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Application
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis ModelS
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1
1.8.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Application
2.2.2 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration & Growth Prospect Mapping
3.2.1 Penetration Analysis
3.2.2 Market Driver Analysis
3.2.2.1 Rising Incidence Of Target Disorders
3.2.2.2 Child Or Early Marriages
3.2.2.3 Initiatives By Government And Various Organizations
3.2.3 Market Restraint Analysis
3.2.3.1 Patent expiry of major drugs
3.2.3.2 Lawsuits related to contraceptives
3.3 Women’s Health Market: Business Environment Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestel Analysis
3.4 Clinical Pipeline Analysis
3.5 Approval of Few Drugs in Recent Years
Chapter 4 Women’s Health Market: Drug Analysis
4.1 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Drug Segment
4.1.1 EVISTA
4.1.1.1 Evista market, 2015 - 2026 (USD Million)
4.1.2 XGEVA
4.1.2.1 Xgeva market, 2015 - 2026 (USD Million)
4.1.3 PROLIA
4.1.3.1 Prolia market, 2015 - 2026 (USD Million)
4.1.4 MIRENA
4.1.4.1 Mirena market, 2015 - 2026 (USD Million)
4.1.5 ZOMETA
4.1.5.1 Zometa market, 2015 - 2026 (USD Million)
4.1.6 RECLAST/ACLASTA
4.1.6.1 Reclast/Aclasta market, 2015 - 2026 (USD Million)
4.1.7 MINASTRIN 24FE
4.1.7.1 Minastrin 24FE market, 2015 - 2026 (USD Million)
4.1.8 NUVARING
4.1.8.1 NuvaRing market, 2015 - 2026 (USD Million)
4.1.9 FORTEO
4.1.9.1 Forteo market, 2015 - 2026 (USD Million)
4.1.10 PREMARIN
4.1.10.1 Premarin market, 2015 - 2026 (USD Million)
4.1.11 ACTONEL
4.1.11.1 Actonel market, 2015 - 2026 (USD Million)
4.1.12 ORTHO-TRI-CY LO 28
4.1.12.1 Ortho-Tri-Cy LO 28 market, 2015 - 2026 (USD Million)
Chapter 5 Women’s Health Market: Application Analysis
5.1 Women’s Health Application Market Share Analysis, 2018 & 2026
5.2 Women’s Health Application Market: Segment Dashboard:
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
5.3.1 Postmenopausal Osteoporosis
5.3.1.1 Postmenopausal Osteoporosis Market, 2015 - 2026 (USD Million)
5.3.2 Hormonal Infertility
5.3.2.1 Hormonal Infertility Market, 2015 - 2026 (USD Million)
5.3.3 Endometriosis
5.3.3.1 Endometriosis Market, 2015 - 2026 (USD Million)
5.3.4 Contraceptives
5.3.4.1 Contraceptives Market, 2015 - 2026 (USD Million)
5.3.5 Menopause
5.3.5.1 Menopause Market, 2015 - 2026 (USD Million)
5.3.6 Polycystic Ovary Syndrome (Pcos)
5.3.6.1 Pcos Market, 2015 - 2026 (USD Million)
Chapter 6 Women’s Health Market: Regional Analysis
6.1 Women’s Health Regional Market Share Analysis, 2018 & 2026
6.2 Women’s Health Regional Market: Segment Dashboard
6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.4 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
6.4.1 North America
6.4.1.1 North America Women’s Health Market, 2015 - 2026 (USD Million)
6.4.1.1.1 U.S.
6.4.1.1.1.1 Regulatory & Reimbursement Scenario
6.4.1.1.1.2 U.S. Women’s Health Market, 2015 - 2026 (USD Million)
6.4.1.1.2 Canada
6.4.1.1.2.1 Regulatory & Reimbursement Scenario
6.4.1.1.2.2 Canada Women’s Health Market, 2015 - 2026 (USD Million)
6.4.2 Europe
6.4.2.1 Europe Women’s Health Market, 2015 - 2026 (USD Million)
6.4.2.1.1 Uk
6.4.2.1.1.1 Regulatory & Reimbursement Scenario
6.4.2.1.1.2 Uk Women’s Health Market, 2015 - 2026 (USD Million)
6.4.2.1.2 Germany
6.4.2.1.2.1 Regulatory & Reimbursement Scenario
6.4.2.1.2.2 Germany Women’s Health Market, 2015 - 2026 (USD Million)
6.4.3 Asia Pacific
6.4.3.1 Asia Pacific Women’s Health Market, 2015 - 2026 (USD Million)
6.4.3.1.1 Japan
6.4.3.1.1.1 Regulatory & Reimbursement Scenario
6.4.3.1.1.2 Japan Women’s Health Market, 2015 - 2026 (USD Million)
6.4.3.1.2 China
6.4.3.1.2.1 Regulatory & Reimbursement Scenario
6.4.3.1.2.2 China Women’s Health Market, 2015 - 2026 (USD Million)
6.4.4 Latin America
6.4.4.1 Latin America Women’s Health Market, 2015 - 2026 (USD Million)
6.4.4.1.1 Brazil
6.4.4.1.1.1 Regulatory & Reimbursement Scenario
6.4.4.1.1.2 Brazil Women’s Health Market, 2015 - 2026 (USD Million)
6.4.4.1.2 Mexico
6.4.4.1.2.1 Regulatory & Reimbursement Scenario
6.4.4.1.2.2 Mexico Women’s Health Market, 2015 - 2026 (USD Million)
6.4.5 Middle East And Africa (Mea)
6.4.5.1 MEA women’s health market, 2015 - 2026 (USD Million)
6.4.5.1.1 South Africa
6.4.5.1.1.1 Regulatory & reimbursement scenario
6.4.5.1.1.2 South Africa women’s health market, 2015 - 2026 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
7.3 Company Profiles
7.3.1 ALLERGAN
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.1.5 Swot analysis
7.3.2 BAYER AG
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.2.5 Swot analysis
7.3.3 MERCK & CO., INC.
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.3.5 Swot analysis
7.3.4 PFIZER, INC.
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.4.5 Swot analysis
7.3.5 TEVA PHARMACEUTICAL INDUSTRIES LTD.
7.3.5.1 Company overview
7.3.5.2 Financial Performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.5.5 Swot analysis
7.3.6 AGILE THERAPEUTICS
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 AMGEN, INC.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.7.5 Swot analysis
7.3.8 APOTHECUS PHARMACEUTICAL CORP.
7.3.8.1 Company overview
7.3.8.2 Product benchmarking
7.3.9 ASTRAZENECA
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.9.5 Swot analysis
7.3.10 BLAIREX LABORATORIES, INC.
7.3.10.1 Company overview
7.3.10.2 Product benchmarking
7.3.11 BRISTOL-MYERS SQUIBB COMPANY
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.11.5 Swot analysis
7.3.12 FERRING B.V.
7.3.12.1 Company overview
7.3.12.2 Product benchmarking
7.3.12.3 Strategic initiatives



List of Tables




TABLE 1 List of Secondary Sources
TABLE 2 North America Women’s Health Market, by Country, 2015 - 2026 (USD Million)
TABLE 3 North America Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 4 U.S. Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 5 Drug development process in Canada
TABLE 6 Canada Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 7 Europe Women’s Health Market, by Country, 2015 - 2026 (USD Million)
TABLE 8 Europe Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 9 UK Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 10 Germany Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 11 Asia Pacific Women’s Health market, by country, 2015 - 2026 (USD Million)
TABLE 12 Asia Pacific Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 13 Japan Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 14 China Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 15 Latin America Women’s Health Market, by Country, 2015 - 2026 (USD Million)
TABLE 16 Latin America Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 17 Brazil Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 18 Mexico Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 19 MEA Women’s Health Market, by Country, 2015 - 2026 (USD Million)
TABLE 20 MEA Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 21 South Africa Women’s Health Market, by Application, 2015 - 2026 (USD Million)